{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05886218",
            "orgStudyIdInfo": {
                "id": "2004503"
            },
            "organization": {
                "fullName": "University of California, Davis",
                "class": "OTHER"
            },
            "briefTitle": "Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery",
            "officialTitle": "A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery",
            "therapeuticArea": [
                "Other"
            ],
            "study": "quantitative-neuromuscular-monitoring-and-gastric-bypass-surgery"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-05-23",
            "studyFirstSubmitQcDate": "2023-05-23",
            "studyFirstPostDateStruct": {
                "date": "2023-06-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Neal Fleming, MD, PhD",
                "investigatorTitle": "Clinical Professor",
                "investigatorAffiliation": "University of California, Davis"
            },
            "leadSponsor": {
                "name": "University of California, Davis",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery."
        },
        "conditionsModule": {
            "conditions": [
                "Sugammadex"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "OTHER",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 215,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Quantitative Neuromuscular Function Monitoring",
                    "description": "Quantitative electromyographic (EMG) monitoring"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Oxygen desaturation",
                    "description": "Incidence and magnitude of significant oxygen desaturation",
                    "timeFrame": "24 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "The rate of compliance with muscle relaxant monitoring and reversal protocols",
                    "description": "Rate of compliance (%)",
                    "timeFrame": "24 hours"
                },
                {
                    "measure": "Total intraoperative rocuronium use",
                    "description": "Total dose/kg/hr (mg/kg/hr)",
                    "timeFrame": "24 hours"
                },
                {
                    "measure": "Total sugammadex dose",
                    "description": "Total dose (mg/kg)",
                    "timeFrame": "24 hours"
                },
                {
                    "measure": "Post-operative supplemental oxygen requirement",
                    "description": "Oxygen requirement (FiO2%/hr)",
                    "timeFrame": "24 hours"
                },
                {
                    "measure": "Post-operative unit length of stay",
                    "description": "Length of stay (Hours)",
                    "timeFrame": "7 days"
                },
                {
                    "measure": "Hospital Length of stay",
                    "description": "Length of stay (Hours)",
                    "timeFrame": "7 days"
                },
                {
                    "measure": "Success rate for wearable device",
                    "description": "Rate of compliance (%)",
                    "timeFrame": "24 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* age greater than 18 years\n* scheduled for an elective laparoscopic gastric bypass procedure\n\nExclusion Criteria:\n\n* age less than 18 years\n* pregnancy\n* prisoners\n* significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication\n* patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2\\>98%)",
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients scheduled for surgical procedures in the UC Davis Medical Center main ORs will be screened for potential enrollment.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ana P Arias, BS",
                    "role": "CONTACT",
                    "phone": "916-703-5456",
                    "email": "apaarias@ucdavis.edu"
                },
                {
                    "name": "Julio J Arana Pineda, BA",
                    "role": "CONTACT",
                    "phone": "916-734-4074",
                    "email": "jjaranapineda@ucdavis.edu"
                }
            ],
            "locations": [
                {
                    "facility": "UC Davis Medical Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ana Arias",
                            "role": "CONTACT",
                            "phone": "916-703-5456",
                            "email": "apaarias@ucdavis.edu"
                        },
                        {
                            "name": "Neal Fleming, MD, PhD",
                            "role": "CONTACT",
                            "phone": "916 734-5046",
                            "email": "nwfleming@ucdavis.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}